Advertisement
comparison

bt_logoCOMPARE PMS SCHEMES

A detailed comparison of PMS schemes on parameters like Fee structure, Portfolio, Returns etc
Caliber
Concept Investwell - Legend
Fund Summary
CategoryLarge CapLarge Cap
AUM (₹ cr)116.77UNDISC.
Fixed Fee1.75%2.00%
Variable Fee0.00%1.50%
Hurdle Rate12%7.00%
Profit Sharing10% Profit Sharing above 12% Hurdle10.00% Profit sharing above 7.00% Hurdle
BenchmarkNifty 50 TRIS&P BSE 500 TRI
Portfolio Age4 years, 9 months16 years, 5 months
Trailing Returns
Portfolio Manager
Umesh Gupta
Umesh Gupta
Siddharth Mandalaywala
Siddharth Mandalaywala
ProfileUmesh Gupta is the Head of Equities PMS at Ambit Global Private Client and the Portfolio Manager of Alpha Growth. He brings over 22 years of experience, with 19 years dedicated to the Indian capital markets. Prior to Ambit, he was the Head of Equities at Avendus Capital (2018–2020), Portfolio Manager at Reliance Private Client (2013–2018), and AVP – Research & Assistant Portfolio Manager at Reliance Private Client (2010–2013). He also worked as an Equity Research Analyst at Dalal & Broacha Stock Broking and Sharekhan (2005–2010), and as a Credit Officer & Business Analyst at Cholamandalam Finance and Consortium Finance (1999–2005). He holds a B.Com degree and an MBA from IMT Ghaziabad.
Detailed Portfolio
Allocation by Market Cap
  • Large Cap 54.97%
  • Mid Cap 35.63%
  • Small Cap 5.07%
  • Large Cap 68%
  • Mid Cap 10%
  • Small Cap 13.5%
Sector Holdings
Capital Goods
7.64%
Financial Services
41.97%
Metals & Mining
10.35%
Services
5.64%
Telecommunication
5.55%
Bank
24%
Diamond & Jewellery
6.5%
ETF
8.5%
Insurance
15%
IT
10%
Stock Holdings
Bajaj Finance Ltd
4.69%
Interglobe Aviation Ltd
5.64%
Jindal Steel Ltd
4.67%
Shriram Finance Ltd
4.95%
Axis Bank Ltd.
5%
HDFC Bank Ltd.
8%
ICICI Lombard General Insurance Co Ltd.
5%
Infosys Ltd
10%
State Bank of India Ltd
7%
Investment Details
Min. Investment50000005000000
SIP OptionAvailableNot Available
STP OptionAvailableNot Available
Exit Load Exit load is 0% Exit load is 2.00% if redeemed in 0-1 year, 0% thereafter.